Salivary exosomal PSMA7: a promising biomarker of inflammatory bowel disease

Xiaowen Zheng, Feng Chen, Qian Zhang, Yulan Liu, Peng You, Shan Sun, Jiuxiang Lin, Ning Chen

PDF(879 KB)
PDF(879 KB)
Protein Cell ›› 2017, Vol. 8 ›› Issue (9) : 686-695. DOI: 10.1007/s13238-017-0413-7
RESEARCH ARTICLE
RESEARCH ARTICLE

Salivary exosomal PSMA7: a promising biomarker of inflammatory bowel disease

Author information +
History +

Abstract

Inflammatory bowel disease (IBD) is an intestinal immune-dysfunctional disease worldwide whose prevalence increasing in Asia including China. It is a chronic disease of the gastrointestinal tract with unknown cause. Exosomes are small vesicles in various body fluids. They have diameters of 40–120 nm, and one of their functions is long-distance transfer of various substances. In this study, we investigated the contents of salivary exosomes in patients with IBD and in healthy controls to explore a new biomarker in patients with IBD. In this study, whole saliva was obtained from patients with IBD (ulcerative colitis (UC), n= 37; Crohn’s disease (CD), n= 11) and apparently healthy individuals (HC, n= 10). Salivary exosomes were extracted from samples, and the proteins within the exosomes were identified by liquid chromatograph-mass spectrometer (LCMS/MS). The results showed that more than 2000 proteins were detected in salivary exosomes from patients with IBD. Through gene ontology analysis, we found that proteasome subunit alpha type 7 (PSMA7) showed especially marked differences between patients with IBD and the healthy controls, in that its expression level was much higher in the CD and UC groups. This exosomal protein is related to proteasome activity and inflammatory responses. So we conclude that in this research, salivary exosomal PSMA7 was present at high levels in salivary exosomes from subjects with IBD. It can be a very promising biomarker to release the patients from the pain of colonoscopy.

Keywords

exosomes / inflammatory bowel disease / proteomics / PSMA7

Cite this article

Download citation ▾
Xiaowen Zheng, Feng Chen, Qian Zhang, Yulan Liu, Peng You, Shan Sun, Jiuxiang Lin, Ning Chen. Salivary exosomal PSMA7: a promising biomarker of inflammatory bowel disease. Protein Cell, 2017, 8(9): 686‒695 https://doi.org/10.1007/s13238-017-0413-7

References

[1]
AzmiAS, BaoB, SarkarFH (2013) Exosome in cancer development, metastasis and resistance: a comprehensive review.Cancer Metastasis Rev32:623–642
CrossRef Google scholar
[2]
BachDH, HongJY, ParkHJ, SkLee (2017) The role of exosomes and miRNAs in drug-resistance of cancer cells.Int J Cancer.
CrossRef Google scholar
[3]
Benito-MartinA, UceroAC, ZubiriI, Posada-AyalaM, Fermandez-FernandezB, Cannata-OrtizP, Sanchez-NinoMD, Ruiz-OrtegaM, EqidoJ, Alvarez-LlamasG (2013) Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine.PLoS ONE8:e72387
CrossRef Google scholar
[4]
BianZ, LiL, CuiJ, ZhangH, LiuY, ZhangCY, ZenK (2011) Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis.J Pathol225:544–553
CrossRef Google scholar
[5]
ChanPP, WasingerVC, LeongRW (2016) Current application of proteomics in biomarker discovery for inflammatory bowel disease.World J Gastrointest Pathophysiol7:27–37
CrossRef Google scholar
[6]
ChoiDS, ParkJO, JangSC, YoonYJ, JungJW, ChoiDY, KimJW, KangJS, ParkJ(2011) Proteomic analysis of microvesicles derived from human colorectal cancer ascites.Proteomics11:2745–2751
CrossRef Google scholar
[7]
DowellJA, FrostDC, ZhangL, LiL (2008) Comparison of twodimensional fractionation techniques for shotgun proteomics.Anal Chem80:6715–6723
CrossRef Google scholar
[8]
HonmaK, TakemasaI, MatobaR, YamamotoY, TakeshitaF, MoriM, MondenM, MatsubaraK, OchiyaT (2009) Screening of potential molecular targets for colorectal cancer therapy. Int J Gen Med2:243–257
[9]
HuXT, ChenW, ZhangFB, ShiQL, HuJB, GengSM, HeC (2009) Depletion of the proteasome subunit PSMA7 inhibits colorectal cancer cell tumorigenicity and migration.Oncol Rep22:1247–1252
[10]
LaiRC, YeoRW, TanKH, LimSK (2013) Exosomes for drug delivery- a novel application for the mesenchymal stem cell.Biotechnol Adv31:543–551
CrossRef Google scholar
[11]
LankaraniKB, SivandzadehGR, HassanpourS (2013) Oral manifestation in inflammatory bowel disease.World J Gastroenterol19:8571–8579
CrossRef Google scholar
[12]
LauC, KimY, ChiaD, SpielmannN, EiblG, ElashoffD, WeiF, LinYL, MoroA, GroganT (2013) Role of pancreatic cancerderived exosomes in salivary biomarker development.J Biol Chem288:26888–26897
CrossRef Google scholar
[13]
MinelliA, MagriC, BarbonA, BonviciniC, SegalaM, CongiuC, BignottiS, MilanesiE, TrabucchiL, CattaneN (2015) Proteasome system dysregulation and treatment resistance mechanisms in major depressive disorder.Transl Psychiatry5:e687
CrossRef Google scholar
[14]
RautavaJ, PinnellLJ, VongL, AkseerN, AssaA, ShermanPM (2015) Oral microbiome composition changes in mouse models of colitis.J Gastroenterol Hepatol30:521–527
CrossRef Google scholar
[15]
RitchieAJ, CrawfordDM, FerqusonDJ, BurthemJ, RobertsDJ (2013) Normal prion proteins is expressed on exosomes isolated from human plasma.Br J Haematol163:678–680
CrossRef Google scholar
[16]
Romanuik UedaT, LeN, HaileS, YongTM, ThomsonT, VessellaRL, SadarMD (2009) Novel biomarkers for prostate cancer including noncoding transcripts.Am J Pathol176:2264–2276
CrossRef Google scholar
[17]
RommelAM, JustinWL, HongJ, RichardJS (2009) Isolation of extracellular membranous vesicle for proteomic analysis.Methods Mol Biol528:227–242
CrossRef Google scholar
[18]
RowlandM, FlemingP, BourkeB (2010) Looking in the mouth for Crohn’s disease.Inflamm Bowel Dis16:332–337
CrossRef Google scholar
[19]
SimpsonRJ, LimJW, MoritzRL, MathibvanaS (2009) Exosomes: proteomic insights and diagnostic potential.Expert Rev Proteomics6:267–283
CrossRef Google scholar
[20]
SiravegnaG, MarsoniS, SienaS, BardelliA (2017) Integrating liquid biopsies into the management of cancer.Nat Rev Clin Oncol.
CrossRef Google scholar
[21]
TandleAT, CalvaniM, UranchimegB, ZahaviD, MelilloG, LibuttiSK (2009) Endothelial monocyte activating polypeptide-II modulates endothelial cell responses by degrading hypoxia-inducible factor-1alpha through interaction with PSMA7, a component of proteasome.Exp Cell Res315:1850–1859
CrossRef Google scholar
[22]
VelosoFT (2011) Extraintestinal manifestations of inflammatory bowel disease: do they influence treatment and outcome?World J Gastroenterol17:2702–2707
CrossRef Google scholar
[23]
VlassovAV, MagdalenoS, SetterquistR, ConradR (2012) Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials.Biochim Biophys Acta1820:940–948
CrossRef Google scholar
[24]
YamadaT, InoshimaY, MatsudaT, IshiguroN (2012) Comparison of methods for isolating exosomes from bovine milk.J Vet Med Sci74:1523–1525
CrossRef Google scholar
[25]
ZhangJ, ZhouS, ZhangQ, FengS, ChenY, ZhengH, WangX, ZhaoW, ZhangT, ZhouY (2014) Proteomic analysis of RBP4/VITAMIN A in children with cleft lip and/or palate.J Dent Res93:547–552
CrossRef Google scholar
[26]
ZhengX, ChenF, ZhangJ, ZhangQ, LinJ (2014) Exosome analysis: a promising biomarker system with special attention to saliva.J Membr Biol247:1129–1136
CrossRef Google scholar

RIGHTS & PERMISSIONS

2017 The Author(s) 2017. This article is an open access publication
AI Summary AI Mindmap
PDF(879 KB)

Accesses

Citations

Detail

Sections
Recommended

/